|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
|
Learn if You Have a Claim Against Manufacturers of DES
Other Drugs / Medical Cases of InterestKahn Gauthier Swick is investigating possible legal actions against nursing homes to recover for injuries suffered by nursing home residents. There are more than one and one-half million elderly and disabled persons in 17,000 nursing homes across the United States. A class action has been filed against neonatal and perinatal physician services provider Pediatrix Medical Group, Inc. (NYSE: PDX) and certain of its officers and directors by stockholders who purchased the company's common stock between April 17, 2002, and June 23, 2003. A class action has been filed against pharmaceutical company SmithKline Beecham Corporation on behalf of all persons who purchased the antidepressant Paxil or Paxil CR (paroxatine) for children under the age of 18 between November 19, 1998, and the present. The suit alleges that the company committed fraud by suppressing clinical study data that indicated Paxil was ineffective for children. Insulin Dependant Diabetics Allege Severe Side Effects from Mis-labled and Substandard Infusion Kits Kahn Gauthier Swick is investigating possible legal actions against Medtronic, Inc. , manufacturer of the Medtronic Quick Set Plus Insulin Infusion Set and the Medtronic Minimed Paradigm Soft Site Insulin Infusion Set. The devices are intended for use by insulin dependent diabetics as an insulin delivery system. The devices are designed to remain in place on the user's body for several days at a time and deliver pre-programmed insulin doses. Severe adverse reactions from use of the infusion sets have been reported as a result of the set's failure to issue programmed insulin doses or to sound a warning alarm to alert users to the device malfunction. Over 200 users of the sets have been hospitalized for treatment of conditions related to the malfunction of the insulin delivery devices. Children are especially susceptible to lead poisoning, which can result in permanent brain damage. A class action has been filed against the Washington, D.C. Water and Sewer Authority (WASA) on behalf of District residents who allege that the Authority has known that their drinking water was contaminated with lead since the summer of 2001, but didn't take any remedial action or notify the public, in violation of federal environmental law. Several class actions have been filed against biopharmaceutical company Genta, Inc. (Nasdaq:GNTA) and certain of its officers and directors by stockholders who purchased the company's common stock between March 26, 2001, and May 3, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. |
Member Benefit!Login above & have the "Personal Information" section pre-populated!
|
||||||||||||||||||||||||||||||||||||||||
Class Action Lawsuit Center ||
Product Recall Center ||
Consumer Complaint Center ||
About LawCash
Link Exchange
Privacy Policy ||
Legal Policies ||
Terms & Conditions ||
Website Advertising Policy ||
Site Map ||
Top Lawsuits
LawCash® is a service of nola3, llc
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
© 2000 - 2008 Copyright. All rights reserved nola3, llc.







